NYSE:CNMDMedical Equipment
A Look At CONMED (CNMD) Valuation After GI Exit, Guidance Raise And Debt Refinancing
CONMED (CNMD) is reshaping its focus after selling its gastrointestinal product portfolio and raising full-year organic growth guidance, while also taking on a new bank term loan that increases interest costs but extends financing flexibility.
See our latest analysis for CONMED.
The refinancing news and portfolio reshaping helped lift the share price, with a 1-day share price return of 6.26%. However, this follows weaker momentum, including a 30-day share price return down 4.12% and a 1-year...